Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Rifamycin, 3-formyl-

Related Products

Hot Products

Name

Rifamycin, 3-formyl-

EINECS 236-311-5
CAS No. 13292-22-3 Density 1.37 g/cm3
PSA 218.38000 LogP 4.70460
Solubility N/A Melting Point 182-184°C
Formula C38H47NO13 Boiling Point 855.4 °C at 760 mmHg
Molecular Weight 725.79 Flash Point 471.1 °C
Transport Information N/A Appearance Black-Red Solid
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 13292-22-3 (3-FORMYL RIFAMYCIN SV) Hazard Symbols N/A
Synonyms

2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-8-carboxaldehyde,1,2-dihydro-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-,21-acetate (7CI,8CI);3-Formylrifampicin SV;3-Formylrifamycin;3-Formylrifamycin SV;NCI 145-635;Rifaldehyde;Rifamycin AF;

Article Data 6

Rifamycin, 3-formyl- Synthetic route

13292-46-1

rifampicin

13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With hydrogenchloride; water at 55℃; for 8h; Temperature;95%
With hydrogenchloride; water In diethyl ether at 20℃; for 96h;89%
With ascorbic acid In hydrogenchloride at 50℃; for 12h;
With isoniazid for 24h;
13292-46-1

rifampicin

13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether; water at 20℃; for 96h;88.9%

C38H48NO16S(1-)*Na(1+)

13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With sodium hydrogencarbonate In water pH=7;78.17 g

C38H48NO16S(1-)*K(1+)

13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With potassium hydrogencarbonate In water pH=7;76.34g
41379-00-4

N1-cinnamyl-N4-amino piperazine

13292-22-3

3-formylrifamycin SV

3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV

Conditions
ConditionsYield
With acetic acid In ethanol at 20 - 30℃; for 2h;98%
123-75-1

pyrrolidine

13292-22-3

3-formylrifamycin SV

108-10-1

4-methyl-2-pentanone

3-[5-methyl-3-(pyrrolidine-1-ylidenium)hex-1-ene-1-yl]rifamycin SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 40 - 52℃; for 0.5h;97.9%
13292-22-3

3-formylrifamycin SV

3973-70-4

1-amino-4-(2-hydroxyethyl)-piperazine

3-(((4-(2-hydroxyethyl)-1-piperazinyl)imino)methyl)rifamycin

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.25h;97%
13292-22-3

3-formylrifamycin SV

56964-23-9

1-amino-4-propargylpiperazine

56964-37-5

C45H58N4O12

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.333333h;97%
In tetrahydrofuran for 0.25h;94%
In tetrahydrofuran at 20℃; for 0.25h; Schlenk technique; Inert atmosphere;91%
123-75-1

pyrrolidine

110-43-0

n-pentyl methyl ketone

13292-22-3

3-formylrifamycin SV

3-[3-(pyrrolidine-1-ylidenium)oct-1-ene-1-yl]rifamycin SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 45 - 50℃; for 2h;91.5%
50-00-0

formaldehyd

768-94-5

1-Adamantanamine

13292-22-3

3-formylrifamycin SV

C49H62N2O12

Conditions
ConditionsYield
In pyridine for 2.75h; Ambient temperature;90%

Rifamycin, 3-formyl- Specification

The Rifamycin, 3-formyl-, with CAS registry number 13292-22-3, belongs to the following product categories: (1)Various Metabolites and Impurities; (2)Intermediates & Fine Chemicals; (3)Metabolites & Impurities; (4)Pharmaceuticals. This chemical is a kind of black-red solid. Its classification code is Drug / Therapeutic Agent. And the chemical formula of this chemical is C38H47NO13. What's more, its EINECS is 236-311-5.

Physical properties of Rifamycin, 3-formyl-: (1)ACD/LogP: 2.85; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): 1.96; (4)ACD/LogD (pH 7.4): 0.24; (5)#H bond acceptors: 14; (6)#H bond donors: 6; (7)#Freely Rotating Bonds: 9; (8)Polar Surface Area: 218.38 Å2; (9)Index of Refraction: 1.633; (10)Molar Refractivity: 188.15 cm3; (11)Molar Volume: 526.5 cm3; (12)Polarizability: 74.58×10-24cm3; (13)Surface Tension: 68.8 dyne/cm; (14)Density: 1.37 g/cm3; (15)Flash Point: 508.3 °C; (16)Enthalpy of Vaporization: 139.67 kJ/mol; (17)Boiling Point: 916.9 °C at 760 mmHg; (18)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: CC(=O)OC1C(C)C(O)C(C)C(O)C(C)\C=C\C=C(\C)C(=O)Nc4c(C=O)c(O)c3c2C(=O)C(C)(O/C=C/C(OC)C1C)Oc2c(C)c(O)c3c4O
(2)InChI: InChI=1/C38H47NO13/c1-16-11-10-12-17(2)37(48)39-28-23(15-40)32(45)25-26(33(28)46)31(44)21(6)35-27(25)36(47)38(8,52-35)50-14-13-24(49-9)18(3)34(51-22(7)41)20(5)30(43)19(4)29(16)42/h10-16,18-20,24,29-30,34,42-46H,1-9H3,(H,39,48)/b11-10+,14-13+,17-12-
(3)InChIKey: BBNQHOMJRFAQBN-AEZIOYLSBJ
(4)Std. InChI: InChI=1S/C38H47NO13/c1-16-11-10-12-17(2)37(48)39-28-23(15-40)32(45)25-26(33(28)46)31(44)21(6)35-27(25)36(47)38(8,52-35)50-14-13-24(49-9)18(3)34(51-22(7)41)20(5)30(43)19(4)29(16)42/h10-16,18-20,24,29-30,34,42-46H,1-9H3,(H,39,48)/b11-10+,14-13+,17-12-
(5)Std. InChIKey: BBNQHOMJRFAQBN-AEZIOYLSSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 416mg/kg (416mg/kg)   United States Patent Document. Vol. #4002754,
mouse LD50 intravenous 299mg/kg (299mg/kg)   "Structure-Activity Relationship among the Semisynthetic Antibiotics," Perlman, D., ed., New York, Academic Press, 1977Vol. -, Pg. 531, 1977.
mouse LD50 oral 907mg/kg (907mg/kg)   United States Patent Document. Vol. #4002754,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13292-22-3